0000937556-19-000140.txt : 20190715 0000937556-19-000140.hdr.sgml : 20190715 20190715175609 ACCESSION NUMBER: 0000937556-19-000140 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190711 FILED AS OF DATE: 20190715 DATE AS OF CHANGE: 20190715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Yongsam CENTRAL INDEX KEY: 0001403400 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33642 FILM NUMBER: 19955910 MAIL ADDRESS: STREET 1: C/O MASIMO CORPORATION STREET 2: 40 PARKER CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MASIMO CORP CENTRAL INDEX KEY: 0000937556 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 330368882 STATE OF INCORPORATION: DE FISCAL YEAR END: 1228 BUSINESS ADDRESS: STREET 1: 52 DISCOVERY CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-297-7000 MAIL ADDRESS: STREET 1: 52 DISCOVERY CITY: IRVINE STATE: CA ZIP: 92618 4 1 wf-form4_156322775422327.xml FORM 4 X0306 4 2019-07-11 0 0000937556 MASIMO CORP MASI 0001403400 Lee Yongsam C/O MASIMO CORPORATION 52 DISCOVERY IRVINE CA 92618 0 1 0 0 EVP & CIO Common Stock 2019-07-11 4 M 0 5339 21.97 A 78339 D Common Stock 2019-07-11 4 S 0 5339 151.3295 D 73000 D Common Stock 2019-07-12 4 M 0 5989 21.97 A 78989 D Common Stock 2019-07-12 4 S 0 5989 151.8345 D 73000 D Common Stock 2019-07-15 4 M 0 1172 21.97 A 74172 D Common Stock 2019-07-15 4 S 0 1172 153.9773 D 73000 D Non-Qualified Stock Option (Right to Buy) 21.97 2019-07-11 4 M 0 5339 21.97 D 2014-05-28 2023-05-28 Common Stock 5339.0 12161 D Non-Qualified Stock Option (Right to Buy) 21.97 2019-07-12 4 M 0 5989 21.97 D 2014-05-28 2023-05-28 Common Stock 5989.0 6172 D Non-Qualified Stock Option (Right to Buy) 21.97 2019-07-15 4 M 0 1172 21.97 D 2014-05-28 2023-05-28 Common Stock 1172.0 5000 D The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of May 23, 2019, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $149.19 per share to a high of $152.705 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $150.56 per share to a high of $153.15 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $151.80 per share to a high of $154.905 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on May 28, 2013 and is exercisable as it vested. This option vested over a five-year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date. /s/ David J. Van Ramshorst - Attorney-in-Fact 2019-07-15